Ruzurgi Amifampridine 10 mg Tablet Bottle
Published 4 October 2021
Product
Ruzurgi amifampridine 10 mg tablet bottle Batch Number: 18039 Exp: 3/2023 Supplied via Special Access Scheme (SAS)
Why it was recalled
The affected product batch 18039 exceeds the specification for total yeast and mould counts (TYMC).
Hazard
The effects of increased exposure to yeast and/or mould can include allergic reactions, asthma, neurotoxicity, sinusitis, otomycosis, onychomycosis, keratitis, respiratory infections, skin infections, and systemic infections. This may pose a serious health risk to users with weakened immune systems.
Source: Product Safety Australia. RecallMatch AU provides a screening summary and is independent of the ACCC.